High SLFN5 expression in melanoma (10), renal cell carcinoma (11), and breast cancer (12) can inhibit tumor invasion and migration, indicating that SLFN5 acts as a tumor suppressor gene. This evidence concerns the gene SLFN5 and breast carcinoma.